REGENT PACIFIC(00575.HK) closed 78.95% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends

NewTimeSpace (newtimespace.com) News, By the close of trading on Jun 17, 2026, REGENT PACIFIC(00575.HK) saw a gain of 78.95% in its share price, closing at HKD 1.02. During the session, it reached an intraday high of HKD 1.22 and touched an intraday low of HKD 0.7. The full-day turnover stood at HKD 4.61 million, with significant volume growth, with the latest market capitalization at HKD 297.65 million.

On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which REGENT PACIFIC belongs, showed an overall divergence trend, with 51 stocks advancing and 93 stocks declining.Among the gainers, REGENT PACIFIC closed higher by 78.95%, CLOVER BIO-B closed higher by 21.97%, HBM HOLDINGS-B closed higher by 10.87%, LUYE PHARMA closed higher by 7.65%, LEE'S PHARM closed higher by 7.62%.Among the decliners, TIANDA PHARMA closed lower by 11%, B&K CORP-B closed lower by 8.37%, MEDTIDE closed lower by 7.82%, SANAI HEALTH GP closed lower by 7.41%, QYUNS-B closed lower by 5.99%.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.